Q3 2023 Holdings
Filed 2023-11-14 | 97 holdings | $3.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $336.7M | 27,692,917 | 11.2% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $220.2M | 10,088,385 | 7.3% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $146.4M | 3,814,691 | 4.9% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $142.3M | 3,965,978 | 4.7% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $113.2M | 2,463,451 | 3.8% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $90.7M | 3,074,542 | 3.0% |
| Lianbio | SPONSORED ADS | 53000N108 | $85.8M | 57,558,451 | 2.9% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $81.9M | 1,619,425 | 2.7% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $78.1M | 4,256,104 | 2.6% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $75.8M | 11,350,085 | 2.5% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $74.0M | 150,600 | 2.5% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $68.5M | 1,342,751 | 2.3% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $65.3M | 4,007,197 | 2.2% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $60.3M | 4,043,191 | 2.0% |
| Meiragtx Hldgs PLC(MGTX) | COM | G59665102 | $55.6M | 11,331,103 | 1.9% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $54.4M | 11,962,938 | 1.8% |
| Lyra Therapeutics Inc(LYRA) | COM | 55234L105 | $49.9M | 12,757,562 | 1.7% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $49.2M | 2,688,873 | 1.6% |
| Bridgebio Pharma(BBIO) | COM | 10806X102 | $46.1M | 1,748,933 | 1.5% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $46.0M | 587,000 | 1.5% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $44.6M | 3,819,456 | 1.5% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $42.1M | 895,641 | 1.4% |
| Immatics N.v(IMTX) | SHS | N44445109 | $40.4M | 3,491,500 | 1.3% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $38.9M | 1,827,901 | 1.3% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $37.6M | 1,263,732 | 1.3% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $36.6M | 1,321,795 | 1.2% |
| Springworks Therapeutics Inc | COM | 85205L107 | $35.2M | 1,520,416 | 1.2% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $33.7M | 481,649 | 1.1% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $32.6M | 996,306 | 1.1% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $31.9M | 1,920,658 | 1.1% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $31.1M | 1,517,467 | 1.0% |
| Nautilus Biotechnology Inc(NAUT) | COM | 63909J108 | $28.8M | 9,111,151 | 1.0% |
| Acrivon Therapeutics Inc(ACRV) | COMMON STOCK | 004890109 | $28.8M | 3,007,858 | 1.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $27.2M | 2,418,968 | 0.9% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $25.0M | 6,984,319 | 0.8% |
| Treace MED Concepts Inc(TMCI) | COM | 89455T109 | $24.0M | 1,834,060 | 0.8% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $23.0M | 1,296,416 | 0.8% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $22.5M | 2,309,470 | 0.8% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $22.1M | 182,720 | 0.7% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $21.2M | 672,042 | 0.7% |
| Orchestra Biomed Hldgs Inc(OBIO) | COM | 68572M106 | $21.2M | 2,432,089 | 0.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $21.1M | 617,500 | 0.7% |
| Verrica Pharmaceuticals Inc | COM | 92511W108 | $19.6M | 5,038,983 | 0.7% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $19.6M | 751,820 | 0.7% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $18.2M | 124,637 | 0.6% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $17.9M | 159,242 | 0.6% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $17.6M | 1,054,273 | 0.6% |
| Rayzebio Inc | COM | 75525N107 | $17.2M | 776,805 | 0.6% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $17.2M | 1,132,491 | 0.6% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $16.3M | 1,943,097 | 0.5% |